Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Medical Research and Opinion

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1185/03007995.2014.921611PMID 24827068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discrete Choice Methods with Simulation

  2016cited by this paper
• Sawtooth Software

  2013cited by this paper
• Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

  2013cited by this paper
• Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51.

  2013cited by this paper
• Physicians’ stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy

  2012cited by this paper
• Apixaban with antiplatelet therapy after acute coronary syndrome.

  2011cited by this paper
• Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial.

  2011cited by this paper
• Valuing citizen and patient preferences in health: recent developments in three types of best–worst scaling

  2010cited by this paper
• Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden.

  2009cited by this paper
• Thrombolytic treatment for stroke: patient preferences for treatment, information, and involvement.

  2009cited by this paper
• [Pathophysiology of coronary artery disease].

  2008cited by this paper
• Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry

  2008cited by this paper
• Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm.

  2007cited by this paper
• Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions.

  2007cited by this paper
• Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

  2007cited by this paper
• "Quick and dirty numbers"? The reliability of a stated-preference technique for the measurement of preferences for resource allocation.

  2006cited by this paper
• Pathophysiology of Coronary Artery Disease

  2005cited by this paper
• Mixed Logit with Bounded Distributions of Correlated Partworths

  2005cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• Patient–physician discordance about benefits and risks in gastroenterology decision‐making

  2004cited by this paper
• Discrete Choice Methods with Simulation by Kenneth E. Train

  2003cited by this paper
• An experiment on simplifying conjoint analysis designs for measuring preferences.

  2003cited by this paper
• Warfarin, aspirin, or both after myocardial infarction.

  2002cited by this paper
• EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper
• Estimating Stated Preferences with Rated-Pair Data: Environmental, Health, and Employment Effects of Energy Programs

  1997cited by this paper
• Bmc Medical Research Methodology Open Access Estimating Preferences for a Dermatology Consultation Using Best-worst Scaling: Comparison of Various Methods of Analysis

  year unknowncited by this paper

• Exploring Methodology for Investigating Chinese Coronary Artery Disease Patient Values and Preferences: A Methodological Study Protocol

  2026cites this paper
• Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making

  2023influential citation
• Impact of Potential Symptoms and Risks Associated with Acid Sphingomyelinase Deficiency on Patients and Caregivers: A Best-Worst Scaling Study

  2023cites this paper
• Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower Registry

  2022cites this paper
• The efficacy of the use of heparin in the emergency room in patients with acute ST-segment elevation myocardial infarction

  2022cites this paper
• Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment.

  2021cites this paper
• Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment

  2021cites this paper
• Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis

  2021cites this paper
• Temporal Trends in in-Hospital Bleeding and Transfusion in a Contemporary Canadian ST-Elevation Myocardial Infarction Patient Population

  2020cites this paper
• Patient Preferences for Osteoarthritis Pain and Chronic Low Back Pain Treatments in the United States: A Discrete-Choice Experiment.

  2020cites this paper
• Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial

  2020cites this paper
• Translating clinical trial results into personalized recommendations by considering multiple outcomes and subjective views

  2019cites this paper
• Optimising antiplatelet utilisation in the acute care setting: a novel threshold for medical intervention in suspected acute coronary syndromes

  2019cites this paper
• Patient preferences for treatment of metastatic melanoma.

  2019cites this paper
• A Guide to Measuring and Interpreting Attribute Importance

  2019cites this paper
• Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

  2019cites this paper
• Benefit–risk evaluation: the past, present and future

  2019cites this paper
• Benefit–Risk Assessments of Medical Treatments

  2019cites this paper
• Parental Preferences for Vesicoureteral Reflux Treatment: A Crowd-sourced, Best-worst Scaling Study.

  2019cites this paper
• Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study

  2018influential citation
• Optimal threshold estimator of a prognostic marker by maximizing a time-dependent expected utility function for a patient-centered stratified medicine

  2018cites this paper
• Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failure

  2017cites this paper
• Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat

  2017cites this paper
• Using Best–Worst Scaling to Investigate Preferences in Health Care

  2016cites this paper
• Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals

  2016cites this paper
• A benefit–risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients

  2016cites this paper
• Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview

  2016cites this paper
• Selecting and Integrating Data Sources in Benefit–Risk Assessment: Considerations and Future Directions

  2016cites this paper
• Les pratiques pharmaceutiques collaboratives en soins de premier recours dans le contexte de l'émergence des TIC

  2016cites this paper
• Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.

  2016cites this paper
• Medical Device Innovation Consortium (MDIC) Patient Centered Benefit-Risk Project (PCBR)

  2015cites this paper